Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Net sales $ 73,639,911 $ 77,792,878 $ 237,221,719 $ 208,167,243
Cost of sales 66,351,871 63,764,512 213,412,253 167,189,136
Gross profit 7,288,040 14,028,366 23,809,466 40,978,107
Selling, general and administrative expense 8,361,500 6,584,407 24,919,946 20,179,278
Acquisition related costs 89,590 180,671 437,610 870,888
Earn-out adjustments (1,241,697) (269,083) (1,642,982) 2,192,574
Operating income 78,647 7,532,371 94,892 17,735,367
Other expense (income)        
Interest expense 943,886 585,888 2,977,624 1,303,724
Change in fair value of interest rate swaps 20,791 (7,490) 144,885 (99,948)
Other, net 179,980 493,413 (224,461) 522,598
(Loss) income before income taxes (1,066,010) 6,460,560 (2,803,156) 16,008,993
Income tax (benefit) provision (112,598) 1,425,002 (660,484) 3,461,000
Net (loss) income $ (953,412) $ 5,035,558 $ (2,142,672) $ 12,547,993
Net (loss) income per common share:        
Basic (in dollars per share) $ (0.11) $ 0.57 $ (0.24) $ 1.43
Diluted (in dollars per share) $ (0.11) $ 0.56 $ (0.24) $ 1.42
Weighted average shares outstanding:        
Basic (in shares) 8,994,851 8,828,523 8,968,782 8,783,876
Dilutive effect from stock options and grants (in shares) 0 105,131 0 73,928
Diluted (in shares) 8,994,851 8,933,654 8,968,782 8,857,804